Octean Pharma ApS: Financial statements 2018
CVR: 38023667
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 844,379 and a net result of DKK 97,173. The profit margin was 11.5%. Equity in the 2018 report amounted to DKK -14,604.
- Revenue
- DKK 844,379
- Gross Profit
- DKK 584,362
- Profit/Loss
- DKK 97,173
- Equity
- DKK -14,604
- Total Assets
- DKK 533,140
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 27, 2018, Lotte Johannesson has stepped down as director of Octean Pharma ApS.
Octean Pharma ApS has published its interim report for the period September 20, 2016 – December 31, 2017.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.